James A. Fyfe
- Epidemiology top 0.5%
- Infectious Diseases top 0.5%
- Molecular Biology top 5%
- Virology top 0.5%
- Oncology top 5%
- Co-authors
- Gertrude B. ElionPhillip A. FurmanPaula ShermanP A FurmanPaul M. KellerLilia M. BeauchampHoward J. SchaefferP de Miranda
- Topics
- Herpesvirus Infections and Treatments (16 papers)Biochemical and Molecular Research (12 papers)HIV/AIDS drug development and treatment (12 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
James A. Fyfe
42 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Epidemiology 3.0k
- Infectious Diseases 2.2k
- Molecular Biology 1.9k
- Virology 1.5k
- Oncology 735
Countries citing papers authored by James A. Fyfe
This map shows the geographic impact of James A. Fyfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Fyfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Fyfe more than expected).
Fields of papers citing papers by James A. Fyfe
This network shows the impact of papers produced by James A. Fyfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Fyfe. The network helps show where James A. Fyfe may publish in the future.
Co-authorship network of co-authors of James A. Fyfe
This figure shows the co-authorship network connecting the top 25 collaborators of James A. Fyfe. A scholar is included among the top collaborators of James A. Fyfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Fyfe. James A. Fyfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 20 | |
| 3 | 12 | |
| 4 | 100 | |
| 5 | 11 | |
| 6 | 12 | |
| 7 | 201 | |
| 8 | 73 | |
| 9 | 10 | |
| 10 | Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.breakdown → | 1167 |
| 11 | 126 | |
| 12 | 32 | |
| 13 | 37 | |
| 14 | 128 | |
| 15 | Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.breakdown → | 476 |
| 16 | 9 | |
| 17 | 7 | |
| 18 | 67 | |
| 19 | 12 | |
| 20 | 35 |
About James A. Fyfe
James A. Fyfe is a scholar working on Virology, Epidemiology and Infectious Diseases, having authored 42 papers that have together received 5.8k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (16 papers), Biochemical and Molecular Research (12 papers) and HIV/AIDS drug development and treatment (12 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (2.2k citations) and Epidemiology (3.0k citations). James A. Fyfe has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Gertrude B. Elion, Phillip A. Furman, Paula Sherman, P A Furman, Paul M. Keller, Lilia M. Beauchamp, Howard J. Schaeffer, P de Miranda, Janet L. Rideout and M H St Clair. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.